Sanofi (SNY) Long-Term Investments (2016 - 2025)
Sanofi's Long-Term Investments history spans 17 years, with the latest figure at $3.8 billion for Q4 2025.
- On a quarterly basis, Long-Term Investments rose 1023.45% to $3.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $3.8 billion, a 1023.45% increase, with the full-year FY2025 number at $3.8 billion, up 1023.45% from a year prior.
- Long-Term Investments hit $3.8 billion in Q4 2025 for Sanofi, down from $4.0 billion in the prior quarter.
- Over the last five years, Long-Term Investments for SNY hit a ceiling of $4.0 billion in Q2 2025 and a floor of $24.0 million in Q4 2021.
- Historically, Long-Term Investments has averaged $1.1 billion across 5 years, with a median of $521.0 million in 2023.
- Biggest five-year swings in Long-Term Investments: crashed 89.98% in 2021 and later skyrocketed 2775.15% in 2022.
- Tracing SNY's Long-Term Investments over 5 years: stood at $24.0 million in 2021, then skyrocketed by 2775.15% to $690.7 million in 2022, then plummeted by 33.95% to $456.2 million in 2023, then decreased by 25.98% to $337.7 million in 2024, then surged by 1023.45% to $3.8 billion in 2025.
- Business Quant data shows Long-Term Investments for SNY at $3.8 billion in Q4 2025, $4.0 billion in Q2 2025, and $337.7 million in Q4 2024.